Sentence examples for growing knowledge regarding from inspiring English sources

The development of biological therapy is based on growing knowledge regarding the molecular changes required in cells for the development and progression of cancer to occur.

Our study showed that three-quarters of children with JIA had hypovitaminosis D. This study adds evidence to the growing knowledge regarding vitamin D and autoimmunity.

Interactions of EDCs with the classical (nuclear) estrogen receptors ER-α and ER-β have been well characterized, and there is also growing knowledge regarding interactions with nonclassical receptors (found elsewhere, as on the cell membrane).

The growing knowledge regarding arrhythmic outcome, risk factors, and life-saving therapeutic interventions, make it particularly timely to critically address and place into perspective the issues relevant to the clinical management of ARVC/D patients.

If that number were to grow, knowledge regarding the efficacy and safety of new therapies would result in new treatments' becoming available at a much faster pace.

These findings contribute a critical component to the growing body of knowledge regarding the medical and clinical outcomes of children with holoprosencephaly.

There is a large and growing body of knowledge regarding so-called Lean best practices, including most recently in the area of program management and systems engineering.

It is with great hope that our growing wealth of knowledge regarding the interaction between the immune system and tumors, together with speedy technological advances, will promote the development of CAR T cell therapy and move toward our ultimate goal curing cancer with high safety, high efficacy, and low cost.

This, in concert with our growing body of knowledge regarding gene and pathway derangements in canine OSA provides insights into the mechanisms of OSA progression and chemoresistance.

Discerning how to interpret "faint bands" and the resulting impacts on malaria misdiagnosis in areas of medium to high transmission and may give different results and therefore we advocate for further research that will add to the growing body of knowledge regarding RDTs and their inherent strengths and limitations.

This study, which relied on data from medical charts from 291 treatment-naïve patients across five countries in Europe, contributes to the growing body of knowledge regarding the tolerability and management of side effects for patients receiving first-line anti-angiogenic agents for the treatment of advanced RCC [ 4, 5, 7– 15].